Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-053162

Director sold 755 shares at $40.73 ($30,751)

From the SEC's structured data for this filing

Trades in this filing

Salter Malcolm · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-20 Sale : show line 1 in the form −755 $40.73 $30,751 13,672 D
Open-market sales · 755 sh · avg $40.73 · $30,751
Loading xslF345X03/doc4.xml…